Registration of phase 3 crossover trials on ClinicalTrials.gov
Abstract Background In a randomized crossover trial, each participant is randomized to a sequence of treatments and treatment effect is estimated based on within-individual difference because each participant serves as his/her own control. This feature makes the design and reporting of randomized cr...
Main Authors: | Lijuan Zeng, Riaz Qureshi, Shilpa Viswanathan, Lea Drye, Tianjing Li |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-07-01
|
Series: | Trials |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13063-020-04545-2 |
Similar Items
-
Comprehensive Survey of Clinical Trials Registration for Melanoma Immunotherapy in the ClinicalTrials.gov
by: Yan-Bo Wang, et al.
Published: (2020-01-01) -
Comparison of published orthopaedic trauma trials following registration in Clinicaltrials.gov
by: Gandhi Rajiv, et al.
Published: (2011-12-01) -
Comprehensive Analysis of Clinical Trials Registration for Lupus Nephritis Therapy on ClinicalTrials.gov
by: Yanfang Gao, et al.
Published: (2021-06-01) -
Updated analysis of pediatric clinical studies registered in ClinicalTrials.gov, 2008–2019
by: Yang Zhong, et al.
Published: (2021-04-01) -
Some data quality issues at ClinicalTrials.gov
by: Neha Chaturvedi, et al.
Published: (2019-06-01)